Find Grants for School Districts
Find out if you qualify for verified grants for School Districts. Discover your eligibility and key funding details for School Districts from major foundations and government agencies.
Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
Deadline: January 11, 2026
Opportunity Number: PAR-25-028
Agency: National Institutes of Health
Open Date: December 11, 2024
Close Date: January 11, 2026
Status: Posted
CFDA Numbers: 93.838, 93.233, 93.839, 93.840, 93.837
Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed)
Deadline: June 18, 2026
Opportunity Number: PAR-25-157
Agency: National Institutes of Health
Open Date: December 10, 2024
Close Date: June 18, 2026
Status: Posted
CFDA Numbers: 93.350
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-321
Agency: National Institutes of Health
Open Date: December 10, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.394, 93.395, 93.393, 93.399, 93.396
BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)
Deadline: June 15, 2026
Opportunity Number: RFA-EY-25-001
Agency: National Institutes of Health
Open Date: December 9, 2024
Close Date: June 15, 2026
Status: Posted
CFDA Numbers: 93.173, 93.286, 93.213, 93.865, 93.866, 93.853, 93.867, 93.273, 93.242, 93.279
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
Deadline: November 2, 2026
Opportunity Number: PAR-24-280
Agency: National Institutes of Health
Open Date: December 9, 2024
Close Date: November 2, 2026
Status: Posted
CFDA Numbers: 93.846
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
Deadline: November 2, 2026
Opportunity Number: PAR-24-279
Agency: National Institutes of Health
Open Date: December 9, 2024
Close Date: November 2, 2026
Status: Posted
CFDA Numbers: 93.846
NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Deadline: March 4, 2027
Opportunity Number: PAR-25-141
Agency: National Institutes of Health
Open Date: December 9, 2024
Close Date: March 4, 2027
Status: Posted
CFDA Numbers: 93.846
Role of Defective Proviruses in HIV Persistence (R01 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-330
Agency: National Institutes of Health
Open Date: December 9, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.847, 93.242, 93.855, 93.865
Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)
Deadline: September 7, 2027
Opportunity Number: PAR-24-330
Agency: National Institutes of Health
Open Date: December 6, 2024
Close Date: September 7, 2027
Status: Posted
CFDA Numbers: 93.838, 93.839, 93.273, 93.866, 93.853, 93.361, 93.399, 93.837, 93.840, 93.233, 93.307
Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)
Deadline: May 7, 2027
Opportunity Number: PAR-25-100
Agency: National Institutes of Health
Open Date: December 6, 2024
Close Date: May 7, 2027
Status: Posted
CFDA Numbers: 93.279
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
Deadline: June 2, 2026
Opportunity Number: RFA-TR-25-002
Agency: National Institutes of Health
Open Date: December 6, 2024
Close Date: June 2, 2026
Status: Posted
CFDA Numbers: 93.350
Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)
Deadline: December 3, 2027
Opportunity Number: RFA-DA-26-055
Agency: National Institutes of Health
Open Date: December 5, 2024
Close Date: December 3, 2027
Status: Posted
CFDA Numbers: 93.273, 93.279
Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
Deadline: December 3, 2027
Opportunity Number: RFA-DA-26-056
Agency: National Institutes of Health
Open Date: December 5, 2024
Close Date: December 3, 2027
Status: Posted
CFDA Numbers: 93.273, 93.279
Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-299
Agency: National Institutes of Health
Open Date: December 5, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.273, 93.307, 93.399
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
Deadline: January 7, 2027
Opportunity Number: PAR-25-025
Agency: National Institutes of Health
Open Date: December 5, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.838, 93.839, 93.233, 93.837
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
Deadline: January 7, 2027
Opportunity Number: PAR-25-026
Agency: National Institutes of Health
Open Date: December 5, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.840, 93.233, 93.839, 93.837, 93.838
NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
Deadline: May 7, 2026
Opportunity Number: PAR-25-239
Agency: National Institutes of Health
Open Date: December 5, 2024
Close Date: May 7, 2026
Status: Posted
CFDA Numbers: 93.121
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
Deadline: November 5, 2027
Opportunity Number: PAR-25-297
Agency: National Institutes of Health
Open Date: December 4, 2024
Close Date: November 5, 2027
Status: Posted
CFDA Numbers: 93.866
Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional)
Deadline: March 20, 2026
Opportunity Number: PAR-25-242
Agency: National Institutes of Health
Open Date: December 4, 2024
Close Date: March 20, 2026
Status: Posted
CFDA Numbers: 93.313, 93.173, 93.865, 93.989, 93.242, 93.399, 93.853, 93.286, 93.867
Accelerating Solutions to Improve Access and Quality of Empirically-Supported Practices for Youth Mental Health (R01 Clinical Trial Optional)
Deadline: January 7, 2027
Opportunity Number: PAR-25-310
Agency: National Institutes of Health
Open Date: December 3, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.242
NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-251
Agency: National Institutes of Health
Open Date: December 3, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.855
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)
Deadline: November 12, 2027
Opportunity Number: PAR-25-215
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: November 12, 2027
Status: Posted
CFDA Numbers: 93.853
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required)
Deadline: November 12, 2027
Opportunity Number: PAR-25-216
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: November 12, 2027
Status: Posted
CFDA Numbers: 93.853
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)
Deadline: November 16, 2027
Opportunity Number: PAR-25-265
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: November 16, 2027
Status: Posted
CFDA Numbers: 93.865
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
Deadline: November 16, 2027
Opportunity Number: PAR-25-266
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: November 16, 2027
Status: Posted
CFDA Numbers: 93.865
